Meihua International Medical Technologies Co., Ltd. (MHUAF)
OTCMKTS · Delayed Price · Currency is USD
7.13
+0.63 (9.69%)
At close: Aug 21, 2026
MHUAF Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 61.79 | 96.91 | 97.1 | 103.35 | 104.04 | |
Revenue Growth | -36.24% | -0.19% | -6.04% | -0.66% | 16.82% |
Cost of Revenue | 42.66 | 63.7 | 64 | 65.38 | 64.36 |
Gross Profit | 19.13 | 33.21 | 33.1 | 37.97 | 39.68 |
Selling, General & Admin | 7 | 13.7 | 13.15 | 18.81 | 10.69 |
Research & Development | 2.38 | 3.46 | 2.75 | 2.96 | 2.73 |
Other Operating Expenses | 0.41 | 0.63 | 0.59 | 0.64 | - |
Operating Expenses | 10.84 | 18.89 | 18.42 | 22.41 | 13.42 |
Operating Income | 8.28 | 14.31 | 14.67 | 15.56 | 26.26 |
Interest Expense | -0.24 | -1.51 | -0.25 | -0.19 | -0.18 |
Interest & Investment Income | 1.26 | 1.01 | 0.87 | 0.06 | 0.02 |
Currency Exchange Gain (Loss) | 0.04 | 0.38 | -0.15 | 0.27 | 0.17 |
Other Non Operating Income (Expenses) | 0.07 | 0.1 | -0.1 | -0.05 | -0.05 |
EBT Excluding Unusual Items | 9.41 | 14.3 | 15.05 | 15.65 | 26.23 |
Other Unusual Items | - | -0.68 | - | -4.76 | - |
Pretax Income | 9.41 | 13.63 | 15.05 | 10.89 | 26.23 |
Income Tax Expense | 2.62 | 2.79 | 3.46 | 4.71 | 5.28 |
Earnings From Continuing Operations | 6.78 | 10.84 | 11.59 | 6.18 | 20.95 |
Minority Interest in Earnings | - | 0.01 | 0.03 | 0.07 | - |
Net Income | 6.78 | 10.84 | 11.63 | 6.24 | 20.95 |
Net Income to Common | 6.78 | 10.84 | 11.63 | 6.24 | 20.95 |
Net Income Growth | -37.46% | -6.73% | 86.22% | -70.20% | 10.00% |
Shares Outstanding (Basic) | 0 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 0 | 0 | 0 | 0 | 0 |
Shares Change | 37.38% | 14.34% | 2.26% | 17.06% | - |
EPS (Basic) | 18.04 | 39.62 | 48.56 | 26.67 | 104.75 |
EPS (Diluted) | 18.04 | 39.62 | 48.56 | 26.67 | 104.75 |
EPS Growth | -54.47% | -18.42% | 82.10% | -74.54% | 10.00% |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 0.55 | 14.5 | 1.09 | -11.86 | -0.9 |
Free Cash Flow Per Share | 1.47 | 52.99 | 4.57 | -50.67 | -4.52 |
Gross Margin | 30.95% | 34.27% | 34.08% | 36.74% | 38.14% |
Operating Margin | 13.41% | 14.77% | 15.11% | 15.05% | 25.24% |
Profit Margin | 10.97% | 11.19% | 11.97% | 6.04% | 20.14% |
Free Cash Flow Margin | 0.90% | 14.97% | 1.13% | -11.48% | -0.87% |
EBITDA | 8.83 | 14.88 | 15.15 | 16.12 | 26.88 |
EBITDA Margin | 14.29% | 15.36% | 15.60% | 15.60% | 25.84% |
D&A For EBITDA | 0.55 | 0.57 | 0.47 | 0.56 | 0.62 |
EBIT | 8.28 | 14.31 | 14.67 | 15.56 | 26.26 |
EBIT Margin | 13.41% | 14.77% | 15.11% | 15.05% | 25.24% |
Effective Tax Rate | 27.90% | 20.47% | 22.98% | 43.28% | 20.13% |
Revenue as Reported | 61.79 | 96.91 | 97.1 | 103.35 | 104.04 |
Advertising Expenses | 0 | 0 | 0.01 | 0.1 | 0.02 |